To include your compound in the COVID-19 Resource Center, submit it here.

Autifony: Sense and sensitivity

Autifony aims to improve auditory processing, prevent persistent hearing damage

Autifony Therapeutics Ltd. is developing compounds for hearing loss and tinnitus that modulate potassium channel Kv3, a target on inhibitory receptors of the CNS that may affect central auditory processing of speech and other sounds.

Age- or noise-related hearing loss may occur as a result of either cochlear damage that reduces signal transduction to the brain or deterioration of central auditory processing and cognitive decline that hinder interpretation of the remaining signal.

Hearing aids have improved speech recognition in quiet, ideal listening environments, but many users find them inadequate for

Read the full 881 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers